Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Pentair Purchases MMP Portfolio™ License

Pentair Purchases MMP Portfolio™ License


CUPERTINO, California – July 26, 2012
– Alliacense announced today Pentair Inc. has purchased an MMP™ Portfolio license. Pentair is a diversified industrial company, providing innovative, sustainable solutions to customers across the globe.

About Alliacense
Alliacense is the recognized leader in the design and execution of Intellectual Property (IP) licensing programs, and delivers peerless IP project support and reverse engineering services. As a cadre of IP licensing strategists, technology experts, and experienced business development/management executives, Alliacense focuses on expanding the awareness and value of IP portfolios under management. Learn more: www.alliacense.com.

About the MMP Portfolio™
The MMP Portfolio patents, originated by The TPL Group in 1989, includes US, European and Japanese patents, covering techniques that enable higher performance and lower cost designs essential to consumer and commercial digital systems ranging from PCs, cell phones and portable music players to communications infrastructure, medical equipment and automobiles. Widely recognized as fundamental technology, the sweeping scope of MMP Portfolio™ technologies continues to encourage the world’s leading companies to become MMP Portfolio™ licensees. Learn more: customerservice@alliacense.com.

Share
New Message
Please login to post a reply